Peter Goodman: His Start-Up May Not Survive Trump’s Tariffs
A sourdough baker turned entrepreneur in North Carolina has delayed his new product as he contemplates the prospect that higher costs will doom his company.…
Thought Leader: Peter Goodman
FDA Needs To Change How It Regulates Novel Technologies
January 12, 2016
Source: Link
By Scott Gottlieb (original source Forbes)
“I spoke before a meeting of the International Society for Stem Cell Research in Berkeley, Calif., this week, addressing the need for the Food and Drug Administration to adapt how it approaches pre-market regulation in order to properly address very novel areas of technology like gene editing and cell and gene therapy.
The thrust of my message was this: FDA needs to more closely focus is organizational structure and its regulatory programs on measures of risk, and move away from its structural legacy that oriented its review programs mostly around discrete clinical areas of medicine.”
Click here to read more
Relevant and recent posts
Tony Abbott calls for stronger action to end ‘pro-Hamas’ protests
Former prime minister Tony Abbott has called for stronger action on antisemitism in the wake of further attacks against the Jewish community, including tougher policing…
Thought Leader: Tony Abbott
Leana Wen: The Doctor Will See You Now. So Will the Lawyer.
Legal aid organizations are helping doctors address social barriers to patients’ health. During my residency training, when I worked shifts in the pediatric emergency department,…
Thought Leader: Leana Wen